CommercialAdministrativeLow impact
07.03.27, Pain Management of Peripheral Nerves by Injection
Independence Blue Cross·Pain Management, Orthopedics, Podiatry +2 more·Pharmacy
We identified it
Jun 19, 2026
Summary
Independence Blue Cross reissued Policy 07.03.27 on 11/26/2025 with no substantive changes to pain management peripheral nerve injection coverage. The policy maintains existing coverage criteria for carpal tunnel syndrome, tarsal tunnel syndrome, and intermetatarsal neuromas, with a 3-injection limit per anatomic site in 6 months and maximum of 2 anatomic sites per session.
Action Required
No immediate action required. This is an annual policy reissuance with no changes to coverage criteria, billing codes, documentation requirements, or clinical guidelines. Billing and clinical teams should maintain current processes for peripheral nerve injection claims. Verify that existing claim submission procedures comply with the 3-injection per site/6-month and 2-site per session limits documented in the policy.